Clinical experiences and methodologic challenges in conducting clinical trials on the behavioral disturbances of dementia

International Psychogeriatrics

Volumn 8, Issue SUPPL. 2, 1996, Pages 151-164

  Finkel, Sanford I ^a   Cooler, Carolyn ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; SERTRALINE; TIOTIXENE;

ARTICLE; BEHAVIOR DISORDER; DEMENTIA; GERONTOPSYCHIATRY; HUMAN; INSTITUTIONALIZATION; MEDICAL ETHICS; SYMPTOM;

EID: 0030432114     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610297003311     Document Type: Article

References (6)

1. Abse, W. D., & Dahlstrom, W. G. (1960). The value of chemotherapy in senile mental disturbances. Journal of the American Medical Association, 174, 2036-2042.
2. Barnes, R., Veith, R., Okimoto, J., Raskind, M., & Gumbrecht, G. (1982). Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. American Journal of Psychiatry, 139, 1170-1174.
3. Barton, R., & Hurst, L. (1966). Unnecessary use of tranquilizers in elderly patients. British Journal of Psychiatry, 112, 989-990.
4. Baumgarten, M., Becker, R., & Gauthier, S. (1990). Validity and reliability of the Dementia Behavior Disturbance Scale. Journal of the American Geriatrics Society, 38, 221-226.
5. United Nations. (1993). World population prospects (1992 rev.). New York: Author.
6. Zimmer, J. G., Watson, N., & Treat, A. (1984). Behavioral problems among patients in skilled nursing facilities. American Journal of Public Health, 74, 1118-1120.